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The maize VP1 protein is a seed-specific regulator of
gene expression that effects the expression of a subset of
abscisic acid (ABA)-regulated genes that are expressed
during the maturation program of the seed. In addition,
VP1 has pleiotropic effects on seed development that are
not related to ABA. In transient expression assays, VP1
has been shown to transactivate gene expression
through at least two distinct promoter elements: the G
boxes from the ABA-inducible wheat Em gene and the
SphI box from the maize C1 gene. We have investigated
how VP1 can transactivate gene expression through di-
verse promoter elements by analyzing its association in
vitro with EmBP-1, a factor that binds the Em promoter.
We demonstrate that VP1 can greatly enhance the DNA
binding activity of EmBP-1 in a gel retardation assay.
This enhancing activity has also been observed on tran-
scription factors as diverse as Opaque-2, Max, Sp1, and
NF-kB. Deletion of a small but highly conserved region
(BR2) in VP1 eliminates the enhancement in vitro as
well as the ability of VP1 to transactivate Em gene ex-
pression in a transient expression assay. A 40-amino
acid fragment from VP1 sandwiched between the mal-
tose-binding protein and LacZ can confer the enhance-
ment function to this fusion protein in vitro. A weak and
relatively nonspecific interaction between BR2 and
DNA is demonstrated by UV cross-linking. The in vitro
properties we observe for VP1 might explain the regu-
latory effects of VP1 on a diverse set of genes and why
mutations in the vp1 locus have pleiotropic effects.
Phytohormones such as abscisic acid (ABA)1 are character-
ized by their ability to mediate a wide range of physiological
responses, one of which is the expression of specific genes that
are organ-, tissue-, or cell-specific (1). Such response pathways
are superimposed upon the developmental regulation of gene
expression. Genetic and biochemical approaches are being used
to understand the mechanism by which a wide variety of hor-
mone-responsive genes are regulated by a single hormone in a
tissue-specific manner (2, 3). For example, a set of genes that
are expressed in the embryo of maturing seeds has been shown
(by embryo culture and mutational studies) to require ABA
(1–3). However, it is becoming clear that ABA-regulated genes
are not only differentially expressed during seed development,
but are differentially controlled in response to ABA in non-
embryonic tissue. For example, a gene in maize (emb5) with
strong homology to the highly conserved seed protein Em gene
(4), as well as the globulin genes in maize (glb1 and glb2) are
expressed exclusively in mid-maturation embryos (5–8). Tran-
scripts of a catalase gene (cat1) and members of the Rab family
(rab17 and rab28), however, accumulate not only in response to
ABA in developing embryos, but in response to ABA in vege-
tative tissues as well (5, 9, 10). Although all of these genes have
the common requirement for ABA for their expression in em-
bryos, they appear to be members of different gene sets con-
trolled by different developmental programs.
Mutations in the viviparous-1 (vp1) regulatory locus in maize
and its equivalent in Arabidopsis, ABA-insensitive 3 (abi3),
have pleiotropic effects during seed maturation, one of which is
to control the sensitivity of cells to ABA. The vp1 mutant fails
to accumulate transcripts of the emb5, glb1, glb2, and other
members of the class I and II gene sets (5) in the presence of
ABA, whereas the cat1 and rab28 genes are expressed in re-
sponse to ABA in vp1 mutant embryos (10, 11). Similar to the
regulation of the emb5 gene, the homologous Em gene in rice
(Emp1) and Em1 in Arabidopsis require both ABA and VP1/
ABI3 for expression in the embryo (12–14). Hence, Em and glb
are examples of genes that require ABA and VP1 for expression
in the embryo, while cat1 and rab28 are examples that require
ABA but not VP1. The VP1/ABI3 protein, which is expressed
only during seed development (6, 14), may be the factor most
directly responsible for the strict regulation of genes that are
expressed exclusively in seeds, e.g. Em. Support for this comes
from the work of Parcy et al. (14), who demonstrated that in
transgenic Arabidopsis plants, overexpression of ABI3 results
in the ectopic expression of the endogenous Em gene (AtEm1)
in vegetative tissue when exposed to ABA.
The complexity and interaction of regulatory circuits opera-
tive during seed maturation is demonstrated further by the fact
that vp1 has very pleiotropic effects during grain development,
suggesting an even broader regulatory function than the ABA
and embryo responses. vp1 kernels exhibit a lack of anthocya-
nins in the non-embryonic aleurone tissue (15, 16), as well as
reduced activities of several seed enzymes in diverse metabolic
pathways (17). These data suggest that the VP1 protein may be
involved in the regulation of a number of diverse genes and
response pathways, only one of which is ABA perception and/or
embryo-specific ABA-regulated gene expression. Although
ABA is an important component of seed maturation and is
essential for the expression of a subset of maturation genes,
various processes and responses associated with seed matura-
* This work was supported in part by National Institutes of Health
Grant GM44288. The costs of publication of this article were defrayed in
part by the payment of page charges. This article must therefore be
hereby marked “advertisement” in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
‡ Recipient of National Research Service Award GM13588-02.
§ Recipient of graduate fellowships from the National Science and
Engineering Research Council of Canada and the Fond pour la Forma-
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tion require factors other than ABA (18), as well as regulatory
loci whose control extends beyond ABA response pathways
(19). Since the Em gene appears to be exclusively expressed in
embryos and requires both ABA and the seed-specific regula-
tory protein VP1, we have focused our studies toward under-
standing how VP1 interacts with the transcriptional control-
ling components of the Em gene.
ABA-responsive cis-sequences in the wheat Em promoter
that have been identified using transient expression assays in
protoplasts of rice (20, 21, 22) and maize (6)2 are shown in Fig.
1A. A 76-bp segment of the Em promoter (Region I) has been
shown to confer ABA responsiveness to the non-responsive 35S
viral promoter (23). Region I includes two copies of a CACGTG
element (Em1a and Em1b), which is a conserved element found
in many plant (24) and other eukaryotic promoters (21), which
flank an AGCAG element (Em2a) that is conserved in certain
genes expressed in seeds (25). Deletion of Region I eliminates
the ABA response, while mutations in either copy of the Em1 (a
or b) or Em2a sequences dramatically reduces the ABA respon-
siveness of the Em promoter (23).3
Previous mobility shift assays and footprinting results with
Region I demonstrated that the Em1a sequence represents a
high affinity binding site for nuclear factors such as EmBP-1, a
basic leucine zipper protein (bZIP) isolated from a wheat em-
bryo cDNA library (21). Competition experiments with various
Em1 elements from both regions I and II using rice nuclear
extracts or bacterially expressed EmBP-1 indicates that the
order of binding preference for nuclear factors is the same as
for EmBP-1.4 A mutation in the CACGTG core of the Em1a
element eliminates binding by nuclear extracts and EmBP-1
and abolishes ABA-induced expression in a rice transient assay
(21).
Does VP1 interact with the Em promoter in the transient
assay, and if so, does VP1 act through the same or different cis
elements and trans factors required for the ABA response?
Transient expression of the vp1 cDNA in maize protoplasts
cotransfected with the wheat or rice Em promoter linked to the
reporter geneGUS, results in GUS expression in the absence of
exogenous ABA (6, 16). In the presence of exogenous ABA, VP1
transactivation of the Em promoter shows a striking synergy in
its transcriptional response, demonstrating that VP1 can aug-
ment the ABA signal in a transient expression system. Tetra-
mers of either the Em1a or Em1b sequences from the wheat
Em promoter are sufficient not only for the ABA response, but
also for the VP1 transactivation and synergy between ABA and
VP1.2 A mutation in the CACGTG core of the Em1a element,
which eliminates the ABA response and EmBP-1 binding (21),
dramatically reduces the VP1 response in maize and rice pro-
toplasts (22).2 These data suggest that the Em1 elements in
Region I of the Em promoter, and the bZIP factors which
recognize them, are the sites through which the ABA and VP1
signals can elicit enhanced transcription (22).2 VP1 can also
transactivate through the SphI element in Region II of the Em
promoter (Fig. 1A), but this is independent of the ABA re-
sponse, since Region II alone cannot support an ABA response.2
The NH2-terminal region of VP1 is required for transactivation
of the Em promoter and can serve as an acidic transcriptional
activator as evidenced by its ability to be functionally replaced
by the acidic domain of the Herpes simplex virus VP16 tran-
scription factor (6). Sequence comparison of the maize VP1
protein (6, 26) with the product of the genetic equivalent locus
in Arabidopsis (abi3) as well as with the rice (13) and bean5
homologs shows three distinct regions that have extremely
high amino acid sequence conservation.
In this paper, we investigate the in vitro interaction between
recombinant VP1 and EmBP-1 proteins and the wheat Em
promoter. We demonstrate in vitro that the VP1 protein en-
hances the binding activity of the bZIP transcription factor
EmBP-1 to Em1 sequences in the Em promoter. The addition of
VP1 to a DNA binding reaction with EmBP-1 appears to in-
crease the effective concentration of EmBP-1 at the Em1 sites
and additionally causes the formation of higher order com-
plexes in a gel shift assay when the target sites are of of low
affinity. VP1 has similar enhancement effects in vitro on a
variety of transcription factors with diverse DNA binding do-
mains and different DNA targets. A 21-amino acid region of the
VP1 protein (BR2), characterized by a basic, a-helical forming
sequence with a high degree of conservation between maize,
rice, bean, and Arabidopsis, is shown to be required for both
transactivation of the Em promoter by VP1 in a transient
protoplast gene expression assay, as well as for the in vitro
DNA binding/enhancing activity. A 40-amino acid fragment
from VP1, which includes BR2, sandwiched between the mal-
tose-binding protein and LacZ can confer the enhancement
function to this fusion protein in vitro. We show also a weak,
relatively nonspecific DNA binding activity of the BR2 region,
which we speculate may alter the conformation of DNA in vitro,
and thus may be responsible for these more general enhance-
ment effects.
EXPERIMENTAL PROCEDURES
Construction of Expression Plasmids—A BssHII/XbaI fragment of
pGCF13, containing an EmBP-1 cDNA, was ligated in frame with the
MBP gene of pPR997 (a preliminary version of New England Biolabs
pMAL-c2 vector obtained from P. Riggs) to give plasmid pAN11. A
partially filled BamHI insert of pAN11 was ligated in the SalI site of
pPR997, yielding pAN14. This plasmid expresses the MBP fused with
amino acids 217–354 of EmBP-1, which includes the bZIP domain.
For expression of the MBP-VP1 fusions, it was necessary to add
EcoRI and HindIII sites next to the start and stop codons of the maize
vp1 cDNA (obtained from D. R. McCarty, University of Florida) by PCR
amplification with the primers ANO-1 (GCGGAATTCATGGAAGC-
CTCCTC) and ANO-3 (GCGAAGCTTTCAGATGCTCAC C). The pAN13
plasmid was then constructed by inserting this amplified product in the
EcoRI/HindIII sites of pPR997. Unfortunately, the MBP-VP1 product of
this plasmid turned out to be extremely unstable. Plasmid pAN15
(MBP-VP1D190), which encodes a VP1 protein that is missing the first
190 amino acids, was obtained by the removal of the EcoRI/BamHI
fragment of pAN13 and blunt ligating. We also received from Don
McCarty plasmids containing the Vp1 deletions Vp1–85/87 (DBR1) and
Vp1–103/104 (DBR2), where amino acids 222–237 and 386–406, respec-
tively, had been removed. BamHI/HindIII inserts from both these plas-
mids were subcloned in the EcoRI/HindIII sites of pPR997. An expres-
sion plasmid encoding amino acids 372–405 of VP1 between the MBP
and lacZ genes was constructed by inserting an MscI/PstI fragment of
the vp1 cDNA in the EcoRI/PstI sites of pPR997.
Finally, an ApaI/HindIII fragment, containing the maize Opaque-2
cDNA (a gift from R. J. Schmidt, University of California, San Diego),
was inserted in the EcoRI/HindIII sites of pPR997 and the EcoRI/
BamHI insert of pPExSD, encoding a rat Max cDNA (obtained from E.
M. Blackwood, University of Washington), was inserted in the same
sites of the expression vector. For expression of MBP-GF-14, the BstUI/
SmaI insert from a cDNA encoding a rice homolog of the maize GF-14
(Ref. 27; received from H. Uchimiya, University of Tokyo) was ligated in
the XmnI site of pPR997.
Purification of Fusion Proteins—Plasmids were transformed in Esch-
erichia coli PR745 (New England Biolabs), and soluble protein extracts
were obtained according to Edgerton and Jones (28) except that a
different column buffer (20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 1 mM
EDTA, 1 mM sodium azide, and 1 mM dithiothreitol) was used and
precipitation with ammonium sulfate was omitted. Fusion proteins
2 Vasil, V., Marcotte, W. R., Jr., Rosenkrans, L., Cocciolone, S., Vasil,
I. K., Quatrano, R. S., and McCarty, D. R. (1995) Plant Cell 7, 1511–
1518.
3 J. L. Magnard and R. S. Quatrano, unpublished data.
4 A. Hill and R. S. Quatrano, unpublished results. 5 A. J. Bobbs, personal communication.
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were then purified using 5-ml amylose resin columns as recommended
by the manufacturer (New England Biolabs). Protein concentrations
were determined using a combination of the Bio-Rad protein assay and
band intensity on Coomassie-stained SDS-PAGE.
Purified NF-kB was a gift from A. S. Baldwin (University of North
Carolina). SP1 was obtained from Promega.
DNA Probes—The probe for Region I has been described before (21).
The fragment of the Em promoter that contains Region II was sub-
cloned by purifying a 126-bp Eco0109I-EaeI fragment from pBM113Kp
(20). This fragment was filled in with Klenow polymerase and ligated
into the SmaI site of pUC118, giving rise to pAH2. To generate the
Region II-labeled probe for gel shift assay, an EcoRI/BamHI DNA
fragment from pAH2 (which adds approximately 18 bp of polylinker)
was purified and filled in with Klenow and [32P]dATP. The human
immunodeficiency virus type I kB probe was provided by the Baldwin
laboratory (29). The SP1 GC box was purchased from Promega and
filled in with Klenow polymerase for 32P labeling.
The following DNA oligonucleotides used in the competitive binding





Gel Shift Assay—The indicated proteins or extracts were incubated
with 0.5–2 ng of probe (approximately 10,000–15,000 cpm) for 20 min at
room temperature. All binding reactions included 12 mM Tris, pH 7.9,
12% glycerol, 35 mM KCl, 0.07 mM EDTA, 1 mM dithiothreitol, 7.5 mM
MgCl2. Typically, BSA (0.16 mg/ml) and poly(dI)-(dC) (600 ng to 1
mg/reaction) were added to the binding reactions. Reactions were loaded
onto a 4–5% acrylamide native gel (40:1 mono:bis ratio, 2.5% glycerol)
and run in 25 mM Tris base, 190 mM glycine, and 1 mM EDTA (final pH
8.3). Electrophoresis was carried out at 10 V/cm in a cold room. When
needed, Factor Xa protease digestion was performed according to the
manufacturer’s recommendations (New England Biolabs) on the MBP
fusions separately or together (depending upon the experiment) and
added to the binding reaction without prior removal of the protease.
Transient Assay in Rice Protoplasts—Protoplasts were prepared,
transformed, and assayed for GUS activity as described previously (20),
except that the final incubation was in Krens’ F solution. For cotrans-
formation experiments, 1 mg each of effector and reporter DNAs was
used per 1 3 106 protoplasts. The full-length Vp1 cDNA effector con-
struct (pCR349.13s) was made by blunt end-ligating a Klenow-filled
2.0-kilobase pair EcoRI/HindIII fragment from pAN13 into a SmaI-
digested and phosphatase-treated pDH51 (30). The Vp1DBR2 construct
(pAG6–20) was made by ligating a 0.8-kilobase pair SmaI/EspI frag-
ment from D. McCarty’s Vp1–103/104 construct into a similarly di-
gested pCR349.13s vector. The Em-GUS reporter construct (pBM207)
was a derivative of pBM113Kp (20) that has one ATG translation start
at the 59 end of the GUS transcript.6
UV Cross-linking—Annealed Region I oligonucleotides were filled-in
with Klenow, dATP, dGTP, bromodeoxyuridine, and [a-32P]dCTP; pu-
rified on NucTrap push columns (Stratagene); and diluted to 1 ng/ml. In
a standard cross-linking reaction, 2 mg of fusion protein was incubated
with 1 ng of labeled probe in 20 ml of binding buffer (see above) for 20
min at room temperature. When necessary, 250 ng of unlabeled com-
petitor was added along with the labeled probe. Afterward, the tube was
opened and placed 5 cm under a 70-watt short wave UV lamp on ice for
15 min. Unbound DNA was digested by adding 1 ml of 0.5 M CaCl2 and
10 units of RQ1 DNase (Promega) and incubating at 37 °C for 30 min.
The samples were then separated on an SDS-PAGE gel, which was
subsequently Coomassie-stained, dried, and exposed to x-ray film.
RESULTS
Only Region I of the Em promoter can function as an inde-
pendent ABA response element and in the synergistic interac-
tion of ABA with VP1 (23).2 To account for the enhanced tran-
scription from the Em promoter caused by expression of vp1 in
a transient assay (6), we asked whether the VP1 protein could
interact directly with the DNA in Region I (Fig. 1A) or indi-
rectly via an interaction with EmBP-1 (Fig. 1B), the bZIP
transcription factor that binds specifically to the Em1 se-
quences required for the ABA and VP1 effects.
Fig. 2 demonstrates that under the conditions of our gel shift
assay, a bacterially expressed truncated VP1 (VP1D190; see
“Experimental Procedures” and Fig. 1B) does not directly in-
teract with Region I. Furthermore, the use of an oligonucleotide
selection assay similar to the one described by Blackwell and
Weintraub (31) has failed to identify any DNA sequences that
would bind to VP1D190 in a gel shift assay (data not shown).
However, when recombinant VP1D190 was added to a binding
reaction with EmBP-1 and a Region I probe, a striking en-
hancement of EmBP-1 binding activity was seen (Fig. 2). This
enhancement with VP1D190 is not dependent on the maltose-
binding protein since it is observed whether VP1 and EmBP-1
are present as fusions (1MBP) or after Factor Xa digestion
(2MBP). The amount of added protein was kept constant in the
reactions without VP1 by the addition of MBP-LacZ protein,
which was purified in a manner identical to the other fusion
proteins. No enhancement was observed when VP1 is replaced
either with BSA or with the MBP-LacZ, MBP-GF14, and MBP-
Max fusion proteins. GF14 is a protein shown to be associated
with G box complexes (32), and Max is a mammalian transcrip-
tion factor (33). Bannister and Kouzarides (34) have demon-
strated that basic peptides can enhance the DNA binding ac-
tivity of some transcription factors. The addition of positively
charged poly-L-lysine to levels 50 times greater than the VP1
concentration fails to enhance the protein-DNA complex (data
not shown), demonstrating that the effect of VP1 enhancement
is not due to a nonspecific effect by a basic protein.
In addition to Region I, which contains high affinity binding
sites for EmBP-1, Region II of the Em promoter was tested (Fig.
1A) for binding activity with VP1. Region II contains two ACGT
elements, Em1c and Em1d, which have previously been shown
to be low affinity binding sites for EmBP-1.7 Fig. 2 demon-
strates that, like the result with the Region I probe, VP1 alone
does not form a complex with the Region II probe. The addition,
however, of VP1D190 to the binding reaction with EmBP-1
enhances the original complex of EmBP-1 with the region II
probe and also causes the formation of a series of slower mi-
grating complexes to form. Under these binding conditions, the
higher order complexes are only apparent with the Region II
probe. These same complexes can be observed on the Region II
probe in the absence of VP1, when high concentrations of
EmBP-1 are used in the binding reaction. These complexes
may, therefore, be the consequence of additional molecules of
EmBP-1 associating with the DNA probe and binding to less
favorable or cryptic sites. VP1, in this case, would be increasing
the apparent concentration of EmBP-1. In addition, we have
noted that the enhancement of EmBP-1 by VP1 is consistently
greater when the target probe bears a low affinity binding site
(e.g. Region II compared to Region I; data not shown).
Fig. 3 demonstrates that the VP1-mediated enhancement of
EmBP-1 is dependent upon the concentration of EmBP-1 in the
binding reaction. The ability of VP1 to enhance was measured
over a range of EmBP-1 concentrations from 0.5 to 25 nm.
Maximal enhancement was seen when EmBP-1 was present at
concentrations below 1 nm. This result suggests that VP1 may
be helping to overcome a concentration-dependent step that
limits the extent of DNA binding.
Vp1 Enhances the Association of Other DNA-binding Pro-
teins to DNA—In order to determine if the VP1 effect is specific
to EmBP-1, we tested a wide variety of DNA-binding proteins
including Opaque-2 (O2), a maize bZIP factor (35); Max, a rat
basic helix-loop-helix factor that is known to heterodimerize
6 W. R. Marcotte, Jr., personal communication. 7 A. Hill and R. S. Quatrano, unpublished results.
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with Myc (33); two NF-kB subunits homologous to the c-rel
protooncogene (29); and the zinc finger protein SP1 (36). Both
O2 and Max recognize a target sequence containing an ACGT
core, which enabled us to use both Region I and Region II
probes from the Em promoter (each containing two ACGT
elements with different flanking sequences; see Fig. 1A) to test
for the enhancement of these factors by VP1. The kB target and
the GC box were used in a binding reaction with the NF-kB
subunits and SP1, respectively. In order to see maximal stim-
ulation of binding by VP1 (see Fig. 3), the concentration of
DNA-binding proteins was maintained at a minimum. In some
cases, this resulted in the absence of a visible complex unless
VP1 was included in the binding reaction.
As seen in Fig. 4, the DNA binding activity of these widely
differing transcription factors, to their own or variant target
sites, can be greatly enhanced by the addition of VP1D190. It is
especially interesting to note that for O2, detection of binding
to the ACGT elements in Region II (Em1c and 1d), which are
quite different from its preferred target, was dependent upon
and enhanced by VP1. The enhancement of binding of this
diverse set of transcription factors indicates that the effect of
VP1 is not confined to a specific class or target site.
VP1 Increases the On-rate of DNA Binding—To determine
how VP1 enhances the DNA binding activity of various DNA-
binding proteins, we examined the rate of association of
EmBP-1 with Region I in the absence and presence of VP1.
Fig. 5 demonstrates that, in the absence of VP1, the EmBP-1
complex requires 10 min to reach maximal level. In the pres-
ence of VP1, total DNA binding was greater, as shown previ-
ously, and the complex was formed by 5 min. Thus, VP1 in-
creases the on-rate of DNA binding.
Enhancement of EmBP-1 Binding Activity in Vitro and
FIG. 1. Map of the Em promoter and the EmBP-1 and VP1 proteins. A, position and sequence of regulatory elements in the Em gene
promoter. Boxes represent the Em1 (Em1a, Em1b, Em1c, and Em1d) and Em2 (Em2a and Em2b) elements and SphI box identified by functional
assays or by their sequence homologies to known cis elements. Position of these elements is given relative to the translation start site (the A of the
ATG codon is coordinate 0). The arrows indicate the positions of the two putative transcriptional start sites (20, 21). Region I and Region II brackets
represent the extent of the probes used in the gel shift assays. B, schematic representation of the EmBP-1 and VP1 polypeptides. In the EmBP-1
map, the shaded boxes indicate the position of the proline-rich, basic DNA binding, and leucine zipper dimerization domains. The bar below the
EmBP-1 protein demonstrates that truncated bZIP retains only the basic DNA binding and leucine zipper dimerization domains. In the VP1
protein, the amino-terminal acidic domain is shown as the transcriptional activator. The position of the two basic regions BR1 (amino acids
222–237) and BR2 (amino acids 386–406) deleted from various VP1 constructs are indicated by the shaded boxes. Bars above VP1 represent regions
of high homology with ABI3, an Arabidopsis homolog of VP1 (26). Bars under VP1 represent the extent of the deletion mutants expressed as
maltose binding fusion proteins. D190VP1 is a truncated version of VP1 that is missing the first 190 amino acids. D190DBR1 and D190DBR2 are
derived from D190VP1. The BR2-LacZ is a translational fusion of amino acids 370–409 with the COOH-terminal portion of the LacZ protein.
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Transactivation of the Em Promoter in Vivo Is a Function of the
VP1 Basic Region 2 (BR2)—We next determined the domain(s)
of the VP1 protein that were essential for the observed en-
hancement of EmBP-1 binding. McCarty et al. (37) have shown
genetically that the COOH-terminal 150 amino acids of VP1
are not involved in the regulation of embryo maturation by
ABA. We therefore chose to focus on the upstream regions of
VP1. Two highly conserved regions (BR1 and BR2; Fig. 1B)
outside of the activation domain were tested for their role in the
enhancement activity. Fusion proteins of VP1D190 with dele-
tions of either BR1 (amino acids 222–237) or BR2 (amino acids
386–406) were used in the gel retardation assay with either
full-length EmBP-1 or bZIP, a truncated version of EmBP-1
that retains its DNA binding and dimerization domains (see
Fig. 1B). The gel shift assay in Fig. 6A demonstrates that the
binding of the bZIP domain of EmBP-1 to Region I is enhanced
by the addition of VP1D190. This truncated bZIP protein has
retained the ability both to bind to Region I and to be enhanced
by VP1. When VP1DBR1 is added to the binding reaction, the
same increase in binding activity of bZIP was observed,
whereas, when VP1DBR2 is added, there is no enhanced bind-
ing by bZIP.
To test if the BR2 region can confer the enhancement func-
tion to another protein, a fusion protein was obtained that is
composed of a 40-amino acid peptide from VP1 (amino acid
residues 370–409), which includes the amino acids removed in
the VP1DBR2 deletion, sandwiched between MBP and LacZ.
When this fusion protein was tested, the binding activity of
bZIP was enhanced as much as with the 502-amino acid
VP1D190. Identical results were observed when the full-length
EmBP-1 was used with the same series of recombinant VP1
(Fig. 6B), i.e. VP1D190, the VP1DBR1 deletion, and the MBP-
BR2-LacZ fusion protein enhanced the EmBP-1 DNA binding
activity, while the VP1DBR2 deletion did not. (Note that in Fig.
FIG. 2. Enhancement of EmBP-1 DNA binding activity by VP1.
EmBP-1 and VP1 as fusion protein (1MBP) or digested with Factor Xa
(2MBP) were assayed for DNA binding to radiolabeled Region I or
Region II probes in a gel shift assay. Binding reactions contained
approximately 375 ng of EmBP-1 fusion protein or 60 ng of Factor
Xa-digested EmBP-1 (2MBP). Assays were carried out in the presence
of either 2 mg of MBP-LacZ (2 lanes) or 2 mg of MBP-VP1D190 (1 lanes).
FIG. 3. The degree of VP1-dependent enhancement is depend-
ent upon EmBP-1 concentration. Binding reactions were carried out
with varying quantities of MBP-EmBP-1 in the presence of 1.5 mg
MBP-VP1D190 and the 32P-labeled Em1a oligonucleotide. The amount
of retarded probe was quantified using a phosphorimager and ex-
pressed as -fold enhancement.
FIG. 4. VP1 enhances the DNA binding activity of other classes
of transcription factors. Except where noted otherwise, the DNA
binding activity of the following transcription factors was assayed in the
presence of 2 mg of factor Xa-treated MBP-LacZ (2 lanes) or MBP-
VP1D190 (1 lanes). A, binding of 600 ng of purified MBP-Opaque2 to
the Region I or Region II probes. B, binding of 100 ng of purified
recombinant MBP-Max with the Region I probe. C, binding of recombi-
nant NF-kB p50 or p65 incubated with the kB probe. D, purified Sp1 (2
ng) was added to a radiolabeled GC box probe in the presence of either
0.9 mg of MBP-LacZ (2 lane) or 0.9 mg of MBP-VP1D190 (1 lane).
FIG. 5. Vp1 increases the rate of association of EmBP-1 with its
binding site. Binding reactions with EmBP-1 fused to MBP were
carried out as in Fig. 3 (1/2 VP1) except that they were incubated for
5 or 10 min at room temperature and loaded onto a gel simultaneously.
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6B the observed enhancement effect is less than that seen in
Fig. 2. This can be explained by the fact that the concentration
of EmBP-1 in the binding reaction is high enough to form a
visible complex, in the absence of VP1. Consequently, the over-
all VP1-dependent enhancement is less). These results clearly
demonstrate that the amino acid residues 386–406 in VP1 are
necessary and sufficient for its enhancing properties and that
deletion of another charged region (BR1) in another part of the
VP1 protein has no effect on in vitro binding enhancement. Fig.
6C is an alignment demonstrating the high degree of conser-
vation of the BR2 domain between VP1 and its homologs in
rice, Arabidopsis, and bean.
McCarty et al. (6) and Vasil et al.2 have demonstrated that
VP1 expressed from a 35S promoter (and the shrunken1 intron)
transactivated different Em-GUS constructs in maize proto-
plasts. We constructed plasmids in which the same full-length
VP1 and VP1DBR2 were fused to a 35S promoter and tested for
Em-GUS transactivation in our rice protoplast transient assay
(23). Table I shows the results of a transient Em-GUS gene
expression assay where full-length VP1 or VP1DBR2 are co-
transfected with the reporter Em-GUS. Expression of full-
length VP1 resulted in a clear transactivation of Em, whereas
expression of the BR2 deletion failed to transactivate an Em-
GUS construct. Although the BR2 deletion construct has an
intact activation domain (amino acids 1–122), which was
shown to be required for transactivation of the Em-GUS fusion
(6), it still fails to transactivate in the rice transient assay. A
ribonuclease protection assay on total RNA from replicate
transfections demonstrates that full-length transcripts of the
transgenes are present in the protoplasts (data not shown).
These results clearly demonstrate that the amino acid residues
386–406 in VP1 are not only necessary and sufficient for the
ability of VP1 to enhance the binding of EmBP-1 to DNA in
vitro, but are required for transactivation of Em in an in vivo
transient expression assay.
UV Cross-linking Shows That BR2 Can Interact with
DNA—We have been unable to obtain evidence that VP1 inter-
acts with EmBP-1 via a protein-protein interaction using im-
munoprecipitation, glutaraldehyde cross-linking, resin binding
FIG. 6. The enhancing activity of
VP1 is mediated through its BR2 do-
main. A, gel shift assay on the Region I
probe using 20 ng of Factor Xa-treated
MBP-bZIP incubated with 300 ng of ei-
ther Factor Xa-treated MBP-LacZ or var-
ious VP1 deletion mutants (see Fig. 2). B,
same experiment as in panel A except
that 8 ng of MBP-EmBP-1 was substi-
tuted for the MBP-bZIP. C, alignment of
BR2 amino acid sequence from maize
with that from rice (13), Arabidopsis (26),
and bean (see Footnote 5). The position of
the BR2 sequences within the context of
the full-length proteins are indicated by
the coordinates at either end of the se-
quence. Vertical lines between the se-
quences indicate conserved residues,
while dots indicate conservative substitu-
tions. The bracketed region above the se-
quence indicates the residues used in
BR2-LacZ, and the bracket below indi-
cates the region removed in the DBR2
constructs.
TABLE I
A full-length Vp1 cDNA expression construct, but not a Vp1DBR2
construct, transactivates a GUS reporter gene driven by the Em
promoter in transformed rice protoplasts
Treatment Rate (6 S.E.)
pmol 4-MU/mg protein/h
No DNA 3.0 6 0.3
Em-GUS 77.6 6 19.0
Em-GUS 1 VP1 690.6 6 56.5
Em-GUS 1 VP1DBR2 67.0 6 15.0
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assays, co-translation in a reticulocyte cell-free system, far-
Western blots, and the yeast two-hybrid system. Since VP1
enhances the binding of widely different transcription factors
and target sites and the effect of VP1 on EmBP-1 binding is
confined to the DNA binding region (bZIP), some essential
functional domain of VP1 could be interacting with DNA,
thereby altering its conformation to enhance binding of se-
quence-specific factors.
Several recombinant proteins were incubated with a Region
I probe that had been labeled with bromodeoxyuridine and
[a-32P]dCTP and cross-linked with UV-light to capture a tran-
sient interaction. Unbound DNAwas then digested with DNase
and the proteins separated on SDS-PAGE. Fig. 7 shows binding
(i.e. labeling) of MBP-BR2-LacZ and our positive control MBP-
EmBP-1 to DNA. No labeling (i.e. binding) was observed using
BSA or the MBP-fusion proteins LacZ, VP1D190 or VP1DBR2.
To determine if the interaction of MBP-BR2-LacZ with DNA is
specific, the cross-linking reactions were repeated in the pres-
ence of a 250-fold excess of either the Em1a element Em2 or
pBluescript DNA that had been cleaved into small fragments
with the restriction endonucleases AluI, BstUI and HaeIII. As
can be seen in Fig. 7B, binding of MBP-BR2-LacZ to region I
was reduced by 40–60% with all competitors. This is in con-
trast to the results obtained with the specific DNA-binding
factor EmBP-1, the labeling of which was totally competed only
by excess Em1a.
DISCUSSION
Our results show that the bacterially expressed VP1D190
protein can enhance the in vitro DNA binding of the bZIP
transcription factor EmBP-1 to its CACGTG binding sites in
Region I of the Em promoter. The enhancing effect on EmBP-1
binding appears to be highly selective for VP1D190 since a
number of other (nonspecific) recombinant proteins expressed
and purified in a manner similar to VP1D190 (e.g. GF14, LacZ,
or Max) failed to enhance the binding of EmBP-1 to its target.
However, the ability of VP1D190 to enhance the binding
activity of transcription factors is not limited to EmBP-1 or its
preferred binding sites. The binding of O2, another member of
the plant bZIP class, to ACGT sites in both Region I and Region
II of the Em promoter is also enhanced by VP1. In addition to
these members of the bZIP class, we show that VP1 also en-
hances the binding of members of the Rel, zinc finger, and basic
helix-loop-helix class of DNA-binding proteins to their target
elements, some of which are different from the ACGT sites for
EmBP-1 and O2. Although dimerization is required for the
bZIPs, Max, and NF-kB to bind DNA, SP1 does not require
dimerization to bind DNA (38). Hence, there is no apparent
specificity of the VP1 effect with respect to class of transcrip-
tion factor, target site, or requirement for dimerization.
These results raise the interesting possibility that the non-
specific enhancement effect displayed by VP1 in vitro could be
reflected in vivo by VP1 transactivating a number of widely
differing genes through diverse promoter elements and tran-
scription factors. This is demonstrated by the ability of VP1 to
transactivate C1, a regulatory gene active in the control of
anthocyanin biosynthesis in the non-embryonic aleurone tis-
sue, and to transactivate the non-ABA-responsive Region II of
the Em promoter (both require an SphI element (CATGCATG)
and not the CACGTG motif essential for its effect on Region I
of the Em promoter (16)).2 These activities of VP1 in vivo and
in vitro are consistent with the very pleiotropic effects of VP1
during seed development (17). Hence, the enhancement effect
by VP1 that we observed may be part of the mechanism by
which VP1 modulates the expression of a broad range of genes
and their associated diverse promoter elements and transcrip-
tion factors.
However, the role of VP1 is not simply to facilitate a general
increase in the expression levels of genes expressed during seed
development. In maize, for example, at least two other ABA-
regulated genes do not require VP1 interactions for expression
in the embryo (10, 11). In Arabidopsis, although the abi3–4
mutation inhibits the accumulation of numerous members of
the different temporal classes of mRNA expressed during seed
development, abi3–4 does not equally affect the accumulation
of all mRNAs in any one temporal class. Hence, the regulatory
networks modulated by VP1/ABI3 in vivo is neither confined
exclusively to any one temporal stage or tissue within the seed
nor to all ABA-regulated genes during seed development. Per-
haps the characteristic in common among the genes in the set
controlled by VP1 is that they are expressed exclusively during
seed development (e.g. Em), in part regulated by the seed-
specific expression of VP1/ABI3. This is supported by the re-
cent demonstration that overexpression of ABI3 in transgenic
Arabidopsis results in the expression of AtEm1 in vegetative
tissue where AtEm1 is normally not expressed (14). Whereas
many other non-VP1/ABI3 regulated genes are expressed in a
temporally and spatially specific pattern during seed develop-
ment in response to various signals including ABA, they may
also be expressed at other times during the life cycle. In any
case, it is apparent that specific regulatory factors other than
VP1 must be involved in the complex regulation of gene expres-
sion in seed maturation and that the nonspecific enhancing
activity we see with VP1 in vitro must somehow be targeted to
a specific subset of genes in the seed that are under VP1
regulation.
The pleiotropic nature of vp1/abi3 in maize and Arabidopsis
FIG. 7. DNA binding activity of the BR2 domain. A, autoradio-
gram of an SDS-PAGE gel after UV cross-linking of approximately 2 mg
of BSA, MBP-LacZ, MBP-VP1D190, MBP-VP1DBR2, MBP-BR2-LacZ,
and MBP-EmBP-1 with a Region I probe. B, labeling of MBP-BR2-LacZ
or MBP-EmBP-1 by UV cross-linking with a Region I probe. Where
indicated, we added a 250-fold excess of the following competitors:
Em1a, Em2a, or digested vector DNA.
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and the absence of specificity associated with the in vitro en-
hancing phenomenon is reminiscent of properties associated
with several transcriptional activators encoded by animal vi-
ruses. The Tax protein encoded by human T-cell lymphotrophic
virus type 1 is a transcriptional activator that can transacti-
vate not only its own viral promoter but also a variety of
cellular enhancers with diverse sequence elements. Armstrong
et al. (39) have demonstrated, using gel shift assays, that the
Tax protein has the ability to enhance the DNA binding of a
variety of transcription factors from different structural classes
including ATF, NF-kB, SP1, and GAL4. This enhancement
phenomenon may explain the highly pleiotropic effects of Tax
on animal cells. Several in vitro characteristics of Tax appear to
be similar to the properties of VP1D190. The Tax enhancement
is not associated with a direct Tax-DNA interaction or a super-
shift (indicative of protein-protein interaction) in gel retarda-
tion assays. Like VP1D190, Tax has been shown to increase the
on rate of bZIP proteins as well as achieve maximal enhance-
ment of DNA binding, when the concentration of DNA-binding
protein is low (40). Wagner and Green proposed that Tax works
by enhancing the ability of bZIP transcription factors to dimer-
ize via a protein-protein interaction with Tax. This mechanism
does not account for the observation that Tax has been shown
to associate with multiple classes of cellular enhancer-binding
proteins that are not bZIP factors, including NF-kB and SRF
(41). The mechanism by which Tax enhances the DNA binding
activity of such a wide range of proteins is not understood.
A different viral transcriptional activator from adenovirus,
E1a, also transactivates through a number of different pro-
moter elements. A recent report (42) presents biochemical ev-
idence that E1a can associate with diverse transcription factor
DNA binding domains, including those from AP-1, SP1, and
USF. E1a appears to associate with various promoters via
protein-protein interactions with a variety of transcriptional
activators. However, the protein-protein association is not sta-
ble enough to survive gel electrophoresis and therefore does not
result in a “supershift.” Likewise, our results with VP1 and the
various DNA-binding proteins in our gel shift analysis show an
enhancement of the original protein-DNA complex, but no de-
tection of a supershift that would indicate formation of a stable
ternary complex. However, unlike E1a, we have been unable to
detect protein-protein interaction between EmBP-1 and VP1. If
protein-protein interaction plays a role, it is extremely tran-
sient and we have been unable to capture it using the various
approaches mentioned above.
Our efforts to identify the domain of VP1 responsible for
enhancement activity, and by so doing elucidate the possible
mode of action of VP1, has been guided by the work of McCarty
et al. (15). The vp1-Mc allele is a transposable element inser-
tion in the vp1 locus causing the production of a truncated VP1
protein missing the COOH-terminal 150 amino acids. This
allele specifically eliminates expression of the anthocyanin but
not the maturation pathway, i.e. the ABA-insensitive pheno-
type. Hence, our efforts have been focused on the sequence of
VP1 upstream of the missing COOH terminus in the vp1-Mc
allele: in particular, two regions that are highly conserved
between Arabidopsis and maize (BR1 and BR2). Our in vitro
results clearly show that a 21-amino acid deletion of the BR2
domain of VP1D190 eliminates the enhancing function of VP1.
That this region is also sufficient for the VP1 effect is further
supported by the fact that a 40-amino acid peptide containing
the BR2 region can confer full enhancing activity to MBP-LacZ.
The functional relevance of the in vitro effects of the BR2
domain of VP1 is supported by transient expression studies in
rice protoplasts. When the deletion of BR2 from the full-length
VP1 protein, is overexpressed behind a 35S promoter, a protein
results that fails to transactivate an Em-GUS construct (Table
I). Although the BR2 deletion fails to activate the Em promoter,
the NH2-terminal acidic activation domain (amino acids 1–122)
that is required for transactivation of Em-GUS (6) is present
and intact. Taken together, these results demonstrate that
both the NH2-terminal acidic region and the BR2 segment are
required for the VP1 function. Since BR2-LacZ lacks an acti-
vation domain, we did not detect transactivation by BR2-LacZ
alone (data not shown).
Because VP1 enhances the binding of widely different tran-
scription factors and target sites, and the effect of VP1 on
EmBP-1 binding is confined to the DNA binding region (bZIP),
we reasoned that some essential functional domain of VP1, e.g.
BR2, could be interacting with DNA in a relatively sequence-
independent way. Such an interaction could alter the confor-
mation of DNA (e.g. promote bending) to enhance binding of a
number of different sequence-specific factors, such as EmBP-1,
O2, etc. The BR2 domain of VP1 is a positively charged region
with helix-forming potential that can form plausible DNA-
binding structures. This region is highly conserved between
VP1 and its homologs in Arabidopsis, rice, and bean (Fig. 6C).
It is clear that the enhancement by VP1D190 is not associated
with a stable VP1-DNA interaction, as evidenced by our inabil-
ity to detect a shifted complex in a gel retardation assay.
However, it appears that the BR2 domain may mediate the
transient association of VP1 with DNA because of our ability to
cross-link MBP-BR2-LacZ to region I. The observation that
BR2 is sufficient both for the enhancing activity and DNA
association suggests that a transient association of VP1 with
DNA might account for its ability to enhance the binding ac-
tivity of other proteins.
We are unable to explain the lack of cross-linking on MBP-
VP1D190. However, one possibility is that the conformation of
BR2 within the context of MBP-VP1D190 is such that its asso-
ciation with DNA is too transient or unstable to capture with
UV cross-linking. Removing BR2 from MBP-VP1D190 and
placing it within the context of a heterologous protein may
serve to unmask the BR2 domain resulting in a more stable
association with DNA. Another possibility is that within the
context of the whole protein, the DNA is not fully protected
against DNase digestion. In any case, the observation that BR2
is sufficient both for the enhancing activity and DNA associa-
tion suggests that a transient association of VP1 with DNA
might account for its ability to enhance the binding activity of
other proteins.
It is possible that VP1 enhances the DNA binding activity of
EmBP-1 by transient stabilization of a local structural confor-
mation in the CACGTG core and that binding of EmBP-1 and
VP1 to the same DNA is mutually exclusive. bZIP factors have
recently been shown to achieve sequence-specific recognition by
binding to a preorganized distorted DNA structure that consti-
tutes the bZIP recognition target (43).
Recently it has been proposed that positively charged protein
domains may contribute to protein-induced DNA bends (44). In
addition, it has been shown that proteins that are known to
bend DNA, for example HMG-1, are associated with enhanced
binding of other DNA-binding proteins in gel retardation as-
says (45, 46). Future investigations will focus on whether the
association of the positively charged BR2 domain with DNA
results in altered DNA structure.
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10. Pla, M., Gómez, J., Goday, A., and Pagès, M. (1991) Mol. & Gen. Genet. 230,
394–400
11. Williamson, J. D., and Scandalios, J. G. (1992) Proc. Natl. Acad. Sci. U. S. A.
89, 8842–8846
12. Litts, J. C., Erdman, M. B., Huang, N., Karrer, E. E., Noueiry, A., Quatrano,
R. S., and Rodriquez, R. L. (1992) Plant Mol. Biol. 19, 335–337
13. Hattori, T., Terada, T., and Hamasuna, S. T. (1994) Plant Mol. Biol. 24,
805–810
14. Parcy, F., Valon, C., Raynal, M., Gaubier-Comella, P., Delseny, M., and
Giraudat, J. (1994) Plant Cell 6, 1567–1582
15. McCarty, D. R., Carson, C. B., Stinard, P. S., and Robertson, D. S. (1989b)
Plant Cell 1, 523–532
16. Hattori, T., Vasil, V., Rosenkrans, L., Hannah, L. C., McCarty, D. R., and
Vasil, I. K. (1992) Genes & Dev. 6, 609–618
17. Dooner, H. K. (1985) Plant Physiol. 77, 486–488
18. Galau, G. A., Jakobsen, K. S., and Hughes, D. W. (1991)Physiol. Plant. 81,
280–288
19. Meinke, D. W., Franzmann, L. H., Nickle, T. C., and Yeung, E. C. (1994) Plant
Cell 6, 1049–1064
20. Marcotte, W. R., Jr., Bayley, C. C., and Quatrano, R. S. (1988) Nature 335,
454–457
21. Guiltinan, M. J., Marcotte, W. R., Jr., and Quatrano, R. S. (1990) Science 250,
267–271
22. Hattori, T., Terada, T., and Hamasuna, S. T. (1995) Plant J. 7, 913–925
23. Marcotte, W. R., Jr., Russell, S. H., and Quatrano, R. S. (1989) Plant Cell 1,
969–976
24. Foster, R., Izawa, T., and Chua, N.-H. (1994) FASEB J. 8, 192–200
25. Litts, J. C., Colwell, G. W., Chakerian, R. L., and Quatrano, R. S. (1991) DNA
Seq. 1, 263–274
26. Giraudat, J., Hauge, B. M., Valon, C., Smalle, J., Parcy, F., and Goodman,
H. M. (1992) Plant Cell 4, 1251–1261
27. Kidou, S., Umeda, M., and Uchimiya, H. (1994) DNA Sequence 5, 125–129
28. Edgerton, M., and Jones, A. M. (1992) Plant Cell 4, 161–171
29. Stein, B., Cogswell, P. C., and Baldwin, A. S., Jr. (1993) Mol. Cell. Biol. 13,
3964–3974
30. Pietrzak M., Shillito, R. D., Hohn, T., and Potrykus, I. (1986) Nucleic Acids
Res. 14, 5857–5868
31. Blackwell, T. K., and Weintraub, H. (1990) Science 250, 1104–1110
32. Lu, G., DeLisle, A. J., de Vetten, N. C., and Ferl, R. J. (1992) Proc. Natl. Acad.
Sci. U. S. A. 89, 11490–11494
33. Blackwood, E. M., and Eisenman, R. N. (1991) Science 251, 1211–1217
34. Bannister, A. J., and Kouzarides, T. (1992) Nucleic Acids Res. 20, 3523
35. Schmidt, R. J., Ketudat, M., Aukerman, M. J., and Hoschek, G. (1992) Plant
Cell 4, 689–700
36. Kadonaga, J. T., Carner, K. R., Masiarz, F. R., and Tjian, R. (1987) Cell 51,
1079–1090
37. McCarty, D. R., Carson, C. B., Lazar, M., and Simonds, S. C. (1989a) Dev.
Genet. 10, 473–481
38. Pascal E., and Tjian, R. (1991) Genes & Dev. 5, 1646–1656
39. Armstrong, A. P., Franklin, A. A., Uittenbogaard, M. N., Giebler, H. A., and
Nyborg, J. K. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 7303–7307
40. Wagner, S., and Green, M. R. (1993) Science 262, 395–399
41. Fujisawa, J., Hirai, H., Suzuki, T., and Yoshida, M. (1993) Hum. Cell. 6,
266–272
42. Liu, F., and Green, M. R. (1994) Nature 368, 520–524
43. Paolella, D. N., Palmer, C. R., and Schepartz, A. (1994) Science 264,
1130–1133
44. Strauss, J. K., and Maher, L. J., III (1994) Science 266, 1829–1834
45. Onate, S. A., Prendergast, P., Wagner, J. P., Nissen, M., Reeves, R., Pettijohn,
D. E., and Edwards, D. P. (1994) Mol. Cell. Biol. 14, 3376–3391
46. Watt, F., and Molloy, P. L. (1988) Nucleic Acids Res. 16, 1471–1486
DNA-binding Enhancement by VP13374
